Longinetti, Elisa
Zhan, Yiqiang http://orcid.org/0000-0001-6016-5665
Sata, Mizuki
Larsson, Henrik
D′Onofrio, Brian M.
Iso, Hiroyasu
Wirdefeldt, Karin
Fang, Fang
Funding for this research was provided by:
Vetenskapsrådet
Karolinska Institute
Article History
Received: 11 April 2020
Accepted: 10 February 2021
First Online: 6 March 2021
Declarations
:
: Henrik Larsson has served as a speaker for Evolan Pharma and Shire and has received research grants from Shire; all outside the submitted work. All other authors report no conflicts of interest.
: The cohort study was approved by the Regional Ethical Review Board in Stockholm, Sweden (Dnr: 2013/862–31/5). The MR analysis used GWAS summary statistics rather than individual-level data and an ethical permit from the institutional review board is not required.